Cargando…
Hypericin-photodynamic therapy leads to interleukin-6 secretion by HepG2 cells and their apoptosis via recruitment of BH3 interacting-domain death agonist and caspases
Photodynamic therapy (PDT) has emerged as a capable therapeutic modality for the treatment of cancer. PDT is a targeted cancer therapy that reportedly leads to tumor cell apoptosis and/or necrosis by facilitating the secretion of certain pro-inflammatory cytokines and expression of multiple apoptoti...
Autores principales: | Barathan, M, Mariappan, V, Shankar, E M, Abdullah, B JJ, Goh, K L, Vadivelu, J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702308/ https://www.ncbi.nlm.nih.gov/pubmed/23807226 http://dx.doi.org/10.1038/cddis.2013.219 |
Ejemplares similares
-
Hypericin, a potential new BH3 mimetic
por: Doroshenko, Anastasia, et al.
Publicado: (2022) -
The Influence of Hypericin-Mediated Photodynamic Therapy on Interleukin-8 and -10 Secretion in Colon Cancer Cells
por: Kaleta-Richter, Marta, et al.
Publicado: (2020) -
Hypericin in the Dark: Foe or Ally in Photodynamic Therapy?
por: Huntosova, Veronika, et al.
Publicado: (2016) -
Molecular profiling of angiogenesis in hypericin mediated photodynamic therapy
por: Bhuvaneswari, Ramaswamy, et al.
Publicado: (2008) -
Photodynamic Effect of Hypericin on the Conformation and Catalytic Activity of Hemoglobin
por: Zhao, Jing, et al.
Publicado: (2008)